Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Nervous system drugs>Antipsychotics>Amisulpride
Amisulpride
  • Amisulpride

Amisulpride NEW

Price $42 $58 $79
Package 25mg 50mg 100mg
Supply Ability: 10g
Update Time: 2026-05-11

Product Details

Product Name: Amisulpride CAS No.: 71675-85-9
Purity: 99.99% Supply Ability: 10g
Release date: 2026/05/11

Product Introduction

Bioactivity

NameAmisulpride
DescriptionAmisulpride (DAN 2163) (trade name Solian) is an antipsychotic drug sold by Sanofi-Aventis. It is not approved for use in the United States, but is approved for use in Europe and Australia for the treatment of psychoses and schizophrenia. Additionally, it is approved in Italy for the treatment of dysthymia (under the brand name Deniban). Amisulpride is a selective dopamine antagonist.
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility InformationEthanol : 65 mg/mL (175.92 mM), Sonication is recommended.
H2O : < 1 mg/mL (insoluble or slightly soluble)
DMSO : 50 mg/mL (135.33 mM), Sonication is recommended.
10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (5.41 mM), Sonication is recommended.
KeywordsInhibitor | inhibit | DopamineReceptor | Dopamine Receptor | Dopamine | DAN-2163 | DAN2163 | Amisulpride | 5HTReceptor | 5HT Receptor | 5-HT
Inhibitors RelatedAlverine citrate | Dapoxetine hydrochloride | Cefaclor monohydrate | Hexamethonium Bromide | Octopamine hydrochloride | 1,8-Cineole | L-DOPA | Creatine | Oxolinic acid | Mianserin hydrochloride | Trazodone hydrochloride | Cinchonidine
Related Compound LibrariesFDA-Approved & Pharmacopeia Drug Library | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Drug Repurposing Compound Library | Cardiotoxicity Compound Library | Inhibitor Library | NO PAINS Compound Library | FDA-Approved Drug Library | Bioactive Compounds Library Max | GPCR Compound Library | NMPA-Approved Drug Library | Anti-Cancer Drug Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

Recommended supplier

Product name Price   Suppliers Update time
$5.00
VIP3Y
Henan Fengda Chemical Co., Ltd
2026-07-03
VIP6Y
WUHAN FORTUNA CHEMICAL CO., LTD
2026-07-03
$999.00
VIP2Y
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
2026-07-03
VIP2Y
Shaanxi Dideu New Materials Co. Ltd
2026-06-30
VIP3Y
Hangzhou Hyper Chemicals Limited
2026-05-29
$10.70
VIP6Y
Hebei Chuanghai Biotechnology Co,.LTD
2026-05-28
$318.00
VIP6Y
Baoji Guokang Healthchem Co., Ltd.
2026-05-15
$95.00
VIP3Y
Zibo Hangyu Biotechnology Development Co., Ltd
2026-05-05
$42.00
VIP6Y
TargetMol Chemicals Inc.
2026-04-22
Moxin Chemicals
2025-12-16

TargetMol Chemicals Inc.

4YR United StatesUnited States
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY